A cuproptosis-related lncRNAs-based risk signature for predicting prognosis and immune status in glioma

Xiangdong Lu, Siquan Zhu, Junzeng Si, Peng Qiu

Open source

DOI
10.21037/tcr-2026-0404
Published
2026-08
Container
Translational Cancer Research
Publisher
AME Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tcr-2026-0404,
  title = {A cuproptosis-related lncRNAs-based risk signature for predicting prognosis and immune status in glioma},
  author = {Xiangdong Lu and Siquan Zhu and Junzeng Si and Peng Qiu},
  year = {2026},
  journal = {Translational Cancer Research},
  doi = {10.21037/tcr-2026-0404},
  url = {https://doi.org/10.21037/tcr-2026-0404}
}

RIS

TY  - JOUR
TI  - A cuproptosis-related lncRNAs-based risk signature for predicting prognosis and immune status in glioma
AU  - Xiangdong Lu
AU  - Siquan Zhu
AU  - Junzeng Si
AU  - Peng Qiu
PY  - 2026
JO  - Translational Cancer Research
DO  - 10.21037/tcr-2026-0404
UR  - https://doi.org/10.21037/tcr-2026-0404
ER  - 

APA

Lu, X., Zhu, S., Si, J., & Qiu, P. (2026). A cuproptosis-related lncRNAs-based risk signature for predicting prognosis and immune status in glioma. Translational Cancer Research. https://doi.org/10.21037/tcr-2026-0404

Source records